Menu Search
Equities

Spectral AI Inc

MDAI:NAQ

Spectral AI Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)1.05
  • Today's Change-0.03 / -2.78%
  • Shares traded251.13k
  • 1 Year change-74.39%
  • Beta0.5785
Data delayed at least 15 minutes, as of Sep 20 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Spectral AI Inc's revenues fell -28.82% from 25.37m to 18.06m. This along with an increase in selling, general and administrative costs has contributed to a reduction in net income from a loss of 2.91m to a larger loss of 20.85m.
Gross margin45.12%
Net profit margin-89.85%
Operating margin-51.84%
Return on assets-150.54%
Return on equity-2,308.32%
Return on investment-954.46%
More ▼

Cash flow in USDView more

In 2023, cash reserves at Spectral AI Inc fell by 9.38m. Cash Flow from Financing totalled 3.84m or 21.29% of revenues. In addition the company used 13.24m for operations while cash used for investing totalled .
Cash flow per share-1.40
Price/Cash flow per share--
Book value per share-0.2422
Tangible book value per share-0.2422
More ▼

Balance sheet in USDView more

Spectral AI Inc has a Debt to Total Capital ratio of 214.16%.
Current ratio0.7231
Quick ratio0.7066
Total debt/total equity--
Total debt/total capital2.14
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.